“The plasma Tumor Necrosis Factor-α (TNF-α) does not have any correlation with disease activity in rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs (DMARDs)”, Braz. J. Pharm. Sci., vol. 56, p. e18551, Dec. 2020, doi: 10.1590/s2175-97902019000418551.